News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 3 years ago
Home  » News » 'Covishield to be sold in private market for Rs 1,000 per dose'

'Covishield to be sold in private market for Rs 1,000 per dose'

Source: PTI   -  Edited By: Roshneesh Kmaneck
January 12, 2021 16:27 IST
Get Rediff News in your Inbox:

Serum Institute of India CEO Adar Poonawalla on Tuesday described the dispatch of Covishield vaccines for the January 16 national inoculation drive a "proud and historic" moment.

IMAGE: Officials unload boxes containing vials of COVISHIELD, a coronavirus disease vaccine manufactured by Serum Institute of India, after a consignment of the vaccines arrived from Pune for its distribution, outside a vaccination storage centre in Ahmedabad. Photograph: Amit Dave/Reuters

Early Tuesday, the first consignment of the vaccines rolled out of the SII facility in Pune for transport to various locations in the country.

 

Speaking to the select media persons at the SII facility, Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable groups of people and to healthcare workers".

"Our trucks left the SII facility early morning and now the vaccine is being distributed in the entire country. This is a proud and historic moment as scientists, experts and all other stakeholders took great efforts while making this vaccine in less than a year," he said.

Poonawalla said the SII has offered the vaccine to the Government of India at a special price of Rs 200.

"This is one of the most affordable vaccines in the world and we are offering it to the GoI at a special price just to support the prime minister's vision and to support the 'aam aadami' of our country," he added.

He also said that once the SII get the requisite permission, the vaccine will be made available in the private market at the cost Rs 1,000.

Poonawalla further said the SII is not only providing the vaccine in India, "but it is also committed to provide it to other countries who are looking at India at this point".

Covishield is developed by Oxford University and British-Swedish company AstraZeneca and manufactured by the SII.

A 'puja' was performed before the three temperature controlled trucks rolled out of Serum Institute gates shortly before 5 am and moved towards the Pune airport, about 15 km away, from where the vaccines were flown across India. 

Get Rediff News in your Inbox:
Source: PTI  -  Edited By: Roshneesh Kmaneck© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
 
Jharkhand and Maharashtra go to polls

Two states election 2024